- Aciphex 5 mg delayed release oral sprinkle capsule 14
- Aciphex Sprinkle rabeprazole sodium Drug Information
- Aciphex - FDA prescribing information, side effects and
- Pediatric Focused Safety Review
Aciphex 5 mg delayed release oral sprinkle capsule 14
FULL PRESCRIBING INFORMATION ACIPHEX is indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD).
Aciphex Sprinkle rabeprazole sodium Drug Information
The purpose of the study is to evaluate the pharmacokinetics, pharmacodynamics and safety of rabeprazole after single and multiple daily administration in children between the ages of 1 and 11 years, inclusive, with GERD.
Aciphex - FDA prescribing information, side effects and
The American Academy of Pediatrics (AAP) has published a guideline on the management of gastroesophageal reflux (GER) in children based on recommendations from the North American and European Societies for Pediatric Gastroenterology, Hepatology, and Nutrition.
Pediatric Focused Safety Review
The purpose of this study is to assess the effectiveness and safety of rabeprazole sodium, an inhibitor of gastric acid secretion of the protein pump inhibitor (PPI) class, compared with placebo in the treatment of gastrointestinal esophageal reflux disease (GERD) in infants 1 to 11 months of age.
Clinical study pediatric gerd aciphex:
Rating: 95 / 100
Overall: 93 Rates